Login to Your Account

Pharma: Other News To Note

Tuesday, September 11, 2012
• ALK-Abello A/S, of Horsholm, Denmark, said it inked a co-promotion deal with MSD (known as Merck & Co. Inc., of Whitehouse Station, N.J., in the U.S. and Canada) for Grazax, a fast-dissolving, once-daily allergy immunotherapy for home treatment of grass pollen allergy in France.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription